• Health & Medicine

Obese people outnumber smokers two to one

People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types. People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types.

3 July 2019

• Health & Medicine

The first complete picture of how long it takes to diagnose cancer in England

Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there's huge variation between referrals. Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there's huge variation between referrals.

30 June 2019

• Policy & Insight
• Health & Medicine

Confessions of a former junk food ad exec  

Advertiser turned campaigner, Dan Parker, talks tricks of the trade and why restrictions on junk food advertising are important.  Advertiser turned campaigner, Dan Parker, talks tricks of the trade and why restrictions on junk food advertising are important. 

25 June 2019

• Health & Medicine

NHS to ‘fast track’ new personalised cancer medicines – but it’s not ready quite yet

NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients. NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.

19 June 2019

• Health & Medicine

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England. Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

19 June 2019

• Health & Medicine

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland. One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

12 June 2019

• Health & Medicine

Lung cancer deaths in women are increasing globally. It’s a hidden but preventable epidemic

With more women dying from lung cancer than ever before, we need to better understand the links between gender and health. With more women dying from lung cancer than ever before, we need to better understand the links between gender and health.

31 May 2019

• Health & Medicine

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.

17 May 2019

• Science & Technology

£6 million fund to boost number of Scots doctors involved in cancer research

Overhaul of clinical training in Scotland to help retain women in the field. Overhaul of clinical training in Scotland to help retain women in the field.

12 May 2019

• Health & Medicine

Prostate cancer MRI scans: is the NHS ready?

All men with suspected prostate cancer should be offered a specialist MRI scan, before a biopsy. That's the new recommendation, but is the NHS ready? All men with suspected prostate cancer should be offered a specialist MRI scan, before a biopsy. That's the new recommendation, but is the NHS ready?

9 May 2019

• Health & Medicine

NICE lung cancer U-turn boosts NHS treatment options in England

A combination treatment for some patients with advanced lung cancer will soon be made available on the NHS in England. A combination treatment for some patients with advanced lung cancer will soon be made available on the NHS in England.

7 May 2019

• Health & Medicine

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England. A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

5 April 2019